NIBE's Vayu Astra-1 passes Army trials with 100 km range, sub-2-metre accuracy

What's new

• NIBE successfully completes technical trials for Vayu Astra-1 loitering munition against Indian Army RFP.
• Trials demonstrate 100 km range, sub-2-metre CEP, and over 90 minutes high-altitude endurance.
• Achievement comes amid a 60% revenue decline and net losses for the micro-cap defence firm.

Why it matters

For a company with a recent 60% revenue decline, this trial output is a lifeline. Validated indigenous loitering munitions are scarce; NIBE now has a product the Army may order from. The question is how quickly procurement converts into revenue — and whether the company's stretched finances can sustain operations until then.

What we're watching

• Whether the Army issues a procurement order following the successful trials.
• NIBE's ability to convert this validated technology into revenue given its recent financial strain.
• Any competitor responses or parallel trials from other loitering munition developers.

The full read

NIBE's Vayu Astra-1 loitering munition has passed its most critical test yet — technical trials against a live Indian Army RFP. The micro-cap defence company, which saw revenues shrink 60% in its latest reported period and is carrying net losses, now has a product that hits the spec: 100 km range, sub-2-metre circular error probable, and over 90 minutes of high-altitude endurance. The trials also included safe recovery, a detail that matters for combat reusability. This is not an order — it's a qualification. But in the Indian defence ecosystem, a validated indigenously developed loitering munition is a rarity. If the Army proceeds to procurement, NIBE's revenue visibility changes entirely. The challenge is timing: the company's cash position and recent losses leave little room for a long gap between trial success and purchase order. What's on the table now is NIBE's most credible shot at turning around.